(Q33372074)

English

Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Ruifang An

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Shu Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Xiaobing Han

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kexiu Zhu

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yan Xue

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

25 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1105-1108

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Treatment of low risk gestational trophoblastic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Liver metastases of gestational trophoblastic tumor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Workshop Report: Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Soci

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Primary oral etoposide therapy in gestational trophoblastic disease. An update.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Secondary chemotherapy for high-risk gestational trophoblastic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Treatment of high-risk gestational trophoblastic tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.031

7 January 2021

Identifiers

10.1016/J.YGYNO.2006.06.031

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33372074&oldid=2010088041"